Flexibility for Your Patients With CIDP
With convenient weekly dosing, patients can fit Hizentra into their normal routine
Self-administration gives you and your CIDP patients the freedom to choose:
Your CIDP patient's routine
How long the self-infusions take
How much medicine is given per infusion
How many infusion sites your patients use
Hizentra provides flexibility for a wide range of patient needs
Has venous access issues
Requires more frequent infusions
Seeks flexibility, freedom, and control
Alice
80-year-old female165 lb (75 kg)
Why Hizentra?
- She doesn't want to face difficulties of nurses finding a vein, nor does she want a port
- Infusing at home is helpful, because she has a caregiver who can assist with the infusions
Weekly dose: 15 g/75 mL
Rate of infusion: 30 mL/hr/site
Infusion sites: 2
Time per infusion: ~1 hour and 15 minutes
Rate of infusion: 30 mL/hr/site
Infusion sites: 2
Time per infusion: ~1 hour and 15 minutes
James
45-year-old male210 lb (95 kg)
Why Hizentra?
- Describes multiple systemic adverse reactions after each IV infusion
- His work and family life are hindered by the serious side effects he has had from IV treatment
Weekly dose: 19 g/95 mL
Rate of infusion: 40 mL/hr/site
Infusion sites: 2
Time per infusion: ~1 hour and 10 minutes
Rate of infusion: 40 mL/hr/site
Infusion sites: 2
Time per infusion: ~1 hour and 10 minutes
Miguel
55-year-old male176 lb (80 kg)
Why Hizentra?
- Going to the IV clinic more often is a hassle– self-infusion at home would give him the freedom and flexibility he needs
- More frequent infusions also mean less volume per infusion and he can infuse in about an hour
Weekly dose: 16 g/80 mL (2 sessions over 2 days)
Rate of infusion: 40 mL/hr/site
Infusion sites: 1
Time per infusion: ~1 hour
Rate of infusion: 40 mL/hr/site
Infusion sites: 1
Time per infusion: ~1 hour
Allison
40-year-old female154 lb (70 kg)
Why Hizentra?
- She needs an infusion regimen that fits her busy work and home-life schedule
- Self-infusion where and when she chooses lets her continue her day without infusion-appointment interruptions
Weekly dose: 14 g/70 mL
Rate of infusion: 45 mL/hr/site
Infusion sites: 2
Time per infusion: ~45 min
Rate of infusion: 45 mL/hr/site
Infusion sites: 2
Time per infusion: ~45 min
Recommended subcutaneous dose is 0.2 g/kg (1 mL/kg) body weight per week. In the clinical study, after transitioning from IVIg to Hizentra, 0.4 g/kg body weight per week was also safe and effective to prevent CIDP relapse.
In the PATH Study
Most CIDP patients reported Hizentra easy to use5
- All patients or caregivers learned to effectively administer Hizentra on their own after 4 or fewer training sessions8
*Based on last postdose observation (n=154). Exploratory endpoint, captured with the TSQM (Treatment Satisfaction Questionnaire for Medication, version 1.4) on a 7-point scale, ranging from extremely difficult to extremely easy. This set was dichotomized into "difficult" for the categories extremely difficult, very difficult, and difficult; and into "easy" for the categories somewhat easy, easy, very easy, and extremely easy.
Self-administration gives patients like James the freedom to infuse at a place and time convenient to them
Patient started Hizentra after years of every 28-day IVIg.
Frequently asked questions about Hizentra for CIDP
Want to know more about Hizentra? We have the answers to prescribers' frequently asked questions.
See the answersHizentra dosing and administration for CIDP
Explore helpful tools for and additional information about self-infusing Hizentra.
See dosing options and administration